These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
804 related articles for article (PubMed ID: 15138590)
21. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells. Zhang S; Lin ZN; Yang CF; Shi X; Ong CN; Shen HM Carcinogenesis; 2004 Nov; 25(11):2191-9. PubMed ID: 15256485 [TBL] [Abstract][Full Text] [Related]
23. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Kazhdan I; Marciniak RA Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201 [TBL] [Abstract][Full Text] [Related]
24. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978 [TBL] [Abstract][Full Text] [Related]
25. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer. Shi YY; Small GW; Orlowski RZ Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678 [TBL] [Abstract][Full Text] [Related]
26. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Grethe S; Ares MP; Andersson T; Pörn-Ares MI Exp Cell Res; 2004 Aug; 298(2):632-42. PubMed ID: 15265709 [TBL] [Abstract][Full Text] [Related]
27. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Jin CY; Park C; Kim GY; Lee SJ; Kim WJ; Choi YH Chem Biol Interact; 2009 Jul; 180(2):143-50. PubMed ID: 19497411 [TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Sanlioglu AD; Koksal IT; Karacay B; Baykara M; Luleci G; Sanlioglu S Cancer Gene Ther; 2006 Jan; 13(1):21-31. PubMed ID: 16052230 [TBL] [Abstract][Full Text] [Related]
29. Expression of TNF-alpha leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-alpha. Yan D; Qin N; Zhang H; Liu T; Yu M; Jiang X; Feng W; Wang J; Yin B; Zhang T; Zhou M; Li Z Breast Cancer Res Treat; 2009 Jul; 116(1):91-102. PubMed ID: 18618239 [TBL] [Abstract][Full Text] [Related]
30. Activation of two distinct anti-proliferative pathways, apoptosis and p38 MAP kinase-dependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375. Hattori T; Hayashi H; Chiba T; Onozaki K Eur Cytokine Netw; 2001; 12(2):244-52. PubMed ID: 11399512 [TBL] [Abstract][Full Text] [Related]
31. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938 [TBL] [Abstract][Full Text] [Related]
33. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027 [TBL] [Abstract][Full Text] [Related]
34. Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. Vega MI; Huerta-Yepaz S; Garban H; Jazirehi A; Emmanouilides C; Bonavida B Oncogene; 2004 Apr; 23(20):3530-40. PubMed ID: 15077178 [TBL] [Abstract][Full Text] [Related]
35. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of LIGHT/interferon-gamma-induced cell death in HT-29 cells. Chang YH; Chao Y; Hsieh SL; Lin WW J Cell Biochem; 2004 Dec; 93(6):1188-202. PubMed ID: 15486969 [TBL] [Abstract][Full Text] [Related]
37. CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Trauzold A; Wermann H; Arlt A; Schütze S; Schäfer H; Oestern S; Röder C; Ungefroren H; Lampe E; Heinrich M; Walczak H; Kalthoff H Oncogene; 2001 Jul; 20(31):4258-69. PubMed ID: 11464292 [TBL] [Abstract][Full Text] [Related]
38. Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades. Shim HY; Park JH; Paik HD; Nah SY; Kim DS; Han YS Anticancer Drugs; 2007 Jul; 18(6):649-57. PubMed ID: 17762393 [TBL] [Abstract][Full Text] [Related]
39. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX; Ong CN; Shen HM Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950 [TBL] [Abstract][Full Text] [Related]
40. The mitogen-activated protein kinase pathway can inhibit TRAIL-induced apoptosis by prohibiting association of truncated Bid with mitochondria. Ortiz-Ferrón G; Tait SW; Robledo G; de Vries E; Borst J; López-Rivas A Cell Death Differ; 2006 Nov; 13(11):1857-65. PubMed ID: 16485030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]